A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours

AIMS: This trial was conducted to evaluate the safety and pharmacokinetics of combretastatin A4 phosphate (CA4P) given intravenously as a single dose to Chinese patients with refractory solid tumours. METHODS: Twenty-five patients were treated with single doses of CA4P according to a dose escalation...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: He, Xuexin, Li, Su, Huang, He, Li, Zhiming, Chen, Likun, Ye, Sheng, Huang, Jiajia, Zhan, Jing, Lin, Tongyu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Blackwell Science Inc 2011
Konular:
Clinical Trials
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3099373/
https://ncbi.nlm.nih.gov/pubmed/21276042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.03928.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller